
ICO
942861273
0
X (Twitter)
975
Address
Wichita
From Social media
News about from their social media (Facebook and X).
Data about organisation
Wichita
Organisations from HUGH O'BRIAN KANSAS YOUTH FOUNDATION

228. South Central Kansas Economic Development District Inc SCKEDD
Growing Small Businesses, Jobs, Communities.

Rebirth Ministries uses speaking, workshops, coaching, and counseling to equip the body of Christ.

232. Substance Abuse Assessment Center of Kansas
Our Mission SACK is a non-profit organization specializing in the prevention, treatment and case management of individuals affected by substance abuse.
Interesting nearby
Interesting organisations close by to residence of HUGH O'BRIAN KANSAS YOUTH FOUNDATION

Midamerica Teachers of English To Speakers of Other Languages Inc
Regional affiliate of TESOL for Iowa, Kansas, Nebraska, and Missouri.
Similar social media (975)
Organisations with similar social media impact to HUGH O'BRIAN KANSAS YOUTH FOUNDATION

168063. Rural Communities Housing Development Corporation
"To Provide Decent and Affordable Housing for Low and Moderate-Income persons".

168064. Hope House Northern Colorado
Empowering teen moms to become personally and economically self-sufficient.

168066. Eau Claire Sober Living Inc
Eau Claire Sober Living is not just sober housing, it is a sober living community.

The mission of Otero Arts is to enrich the lives of the people of our community through the arts.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

🌍 Exciting news from Uganda! Catholic Relief Services is looking for a Project Officer in Monitoring, Evaluation, Accountability, and Learning to join their team. This is a fantastic opportunity to contribute to meaningful change in communities! 💪🙌 #GoodNews #ProSocialImpact
Project Officer - Monitoring, Evaluation, Accountability, and Learning - Uganda
ReliefWeb
Like Comment
Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment